Warm autoimmune hemolytic anemia associated with an IgM autoanti-Ge
Sererat, T., Veidt, D., Arndt, P.A., Garratty, G.
Review: drug-induced immune hemolytic anemia—the last decade
Garratty, G.
An update on drug-induced immune hemolytic anemia
Garratty, G., Arndt, P.A.
Clinical evaluation for lymphoproliferative disease prompted by finding of IgM warm autoanti-IT in two cases
Leger, R.M., Lowder, F., Dungo, M.C., Chen, W., Mason, H.M., Garratty, G.
Screening for RBC antibodies— what should we expect from antibody detection RBCs
Garratty, G.
Attempts to support an immune etiology in 800 patients with direct antiglobulin test–negative hemolytic anemia
Leger, R.M., Co, A., Hunt, P., Garratty, G.
Clinical significance of an anti-Dib assessed by flow cytometry
Leger, R., Arndt, P., CO, A., O’brien, L., Garratty, G.
In vitro reactions with red blood cells that are not due to blood group antibodies: a review
Garratty, G.
How we investigate drug-induced immune hemolytic anemia
Leger, R.M., Arndt, P.A., Garratty, G.
Drugs that have been shown to cause drug-induced immune hemolytic anemia or positive direct antiglobulin tests: some interesting findings since 2007
Garratty, G., Arndt, P.A.
Current viewpoints on mechanisms causing drug-induced immune hemolytic anemia and/or positive direct antiglobulin tests
Garratty, G.
A simple method for inhibiting ABO antibodies in sera used for platelet crossmatching
Postoway, N., Garratty, G.